🇺🇸 FDA
Patent

US 9173862

Methods and compositions for treating and identifying compounds to treat age-related macular degeneration

granted A61KA61K31/00A61K31/07

Quick answer

US patent 9173862 (Methods and compositions for treating and identifying compounds to treat age-related macular degeneration) held by Arizona Board of Regents, A Body Corporate Of The State Of Arizona Acting For An On Behalf Of The University of Arizona expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents, A Body Corporate Of The State Of Arizona Acting For An On Behalf Of The University of Arizona
Grant date
Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/00, A61K31/07, A61K31/195, A61K31/198